Publications by authors named "Clara Mayo"

Claim this Profile
mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.
Mónica Garzón, Sergi Villatoro, Cristina Teixidó, Clara Mayo, Alejandro Martínez

Transl Lung Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal gastrointestinal toxicity with ipilimumab after BRAF/MEK inhibitor combination in a melanoma patient achieving pathological complete response.
Maria Gonzalez-Cao, Aram Boada, Cristina Teixidó, María Teresa Fernandez-Figueras, Clara Mayo

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of a PCR assay for the detection of EGFR mutations in non-small-cell lung cancer: retrospective testing of specimens from the EURTAC trial.
Susana Benlloch, Maria Luisa Botero, Jordi Beltran-Alamillo, Clara Mayo, Ana Gimenez-Capitán

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.
A Jasmijn Hubers, Daniëlle A M Heideman, Yasushi Yatabe, Michelle D Wood, Justyna Tull, Clara Mayo

Lung Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS mutations in lung cancer.
Niki Karachaliou, Clara Mayo, Carlota Costa, Ignacio Magrí, Ana Gimenez-Capitan

Clin Lung Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumors.
Clara Mayo, Francisco G Ortega, Ana Giménez-Capitán, Miguel A Molina-Vila, Maria José Serrano

Transl Lung Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
Niki Karachaliou, Carlota Costa, Ana Gimenez-Capitan, Miguel Angel Molina-Vila, Jordi Bertran-Alamillo, Clara Mayo

J Thorac Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications.
Clara Mayo, Jordi Bertran-Alamillo, Miguel Ángel Molina-Vila, Ana Giménez-Capitán, Carlota Costa

Pharmacogenomics· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.
Mariacarmela Santarpia, Ignacio Magri, Maria Sanchez-Ronco, Carlota Costa, Miguel Angel Molina-Vila, Clara Mayo

J Transl Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.
Rafael Rosell, Miguel Angel Molina, Carlota Costa, Sara Simonetti, Ana Gimenez-Capitan, Clara Mayo

Clin Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Sara Simonetti, Miguel Angel Molina, Cristina Queralt, Itziar de Aguirre, Clara Mayo

J Transl Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for EGFR mutations in lung cancer.
Miguel A Molina-Vila, Jordi Bertran-Alamillo, Clara Mayo, Rafael Rosell

Discov Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for epidermal growth factor receptor mutations in lung cancer.
Rafael Rosell, Teresa Moran, Cristina Queralt, Rut Porta, Felipe Cardenal, Clara Mayo

N Engl J Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin D1 negatively regulates the expression of differentiation genes in HT-29 M6 mucus-secreting colon cancer cells.
Clara Mayo, Xavier Mayol

Cancer Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.
Miguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, Miquel Taron, Eva Castellà, Clara Mayo

J Thorac Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression.
Clara Mayo, Josep Lloreta, Francisco X Real, Xavier Mayol

J Cell Physiol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment.
Josep M de Anta, Clara Mayo, Francesc Solé, Marta Salido, Blanca Espinet, Xavier Mayol

Int J Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis